SpinalCyte Announces Presentations at the American Society of Gene & Cell Therapy (ASGCT) Annual Meeting 2018

HOUSTON–(BUSINESS WIRE)–#cybrocell–SpinalCyte, LLC, a Texas-based regenerative medicine company focused on
regrowth of the spinal disc nucleus using Human Dermal Fibroblasts
(HDFs), today announced poster presentations highlighting a recent
double-blind, placebo controlled human trial of CybroCell™ HDFs to treat
degenerative disc disease along with Superior Immune Modulation for
Arthritis and Treatment of Acute Liver Failure.

Poster Presentation Details:

 

Title:

      Efficacy of CybroCell™ Fibroblast Intradiscal Cellular Therapy for
Disc Degenerative Disease

LINK

Number:

776

Category:

Cell Therapies

Session:

Date & Time: Friday, May 18, 5:45P CDT

Location:

Stevens Salon C, D

Authors:

Pete O’Heeron1, Jesus Perez2, Javier Lopez2,
Amit N. Patel3, Courtney Bartlett3, Thomas E.
Ichim1
 

1SpinalCyte LLC, Houston, TX,2Institute for
Regenerative Medicine, Baja, Mexico,3University of
Miami, Miami, FL

 
 

Title:

      Treatment of Acute Liver Failure Using CybroCell™ Universal Donor
Fibroblast Therapy

LINK

Number:

478

Category:

Cell Therapies

Session:

Date & Time: Thursday, May 17, 5:15P CDT

Location:

Stevens Salon C, D

Authors:

Thomas E. Ichim1, Courtney Bartlett2, Wei-Ping
Min3, Amit N. Patel2, Pete O’Heeron1
 
1SpinalCyte LLC, Houston, TX,2University of
Miami, Miami, FL,3University of Western Ontario, London,
ON, Canada
 
 

Title:

      Superior Immune Modulation and Anti-Arthritic Activity by CybroCell™
Compared to Bone Marrow Mesenchymal Stem Cells.

LINK

Number:

231

Category:

Immunological Aspects of Gene and Cell Therapy

Session:

Date & Time: Thursday, May 17, 5:30P CDT

Location:

Stevens Salon C, D

Authors:

Thomas E. Ichim1, Courtney Bartlett2, Wei-Ping
Min3, Amit N. Patel2, Pete O’Heeron1
 
1SpinalCyte LLC, Houston, TX,2University of
Miami, Miami, FL,3University of Western Ontario, London,
ON, Canada
 

About SpinalCyte, LLC

Based in Houston, Texas, SpinalCyte, LLC is a regenerative medicine
company developing an innovative solution for spinal nucleus replacement
using human dermal fibroblasts. Currently, SpinalCyte holds 25 U.S. and
international issued patents and has filed for an additional 48 patents
pending. Funded entirely by angel investors, SpinalCyte represents the
next generation of medical advancement in cell therapy. Visit www.spinalcyte.com.

Contacts

SpinalCyte, LLC
Investor Contact:
281.461.6211
info@spinalcyte.com
or
Media
Contact:

Dan Keeney, APR, 832.467.2904
dan@dpkpr.com